Analysis shows 2.6% HBsAg, 10.1% HBcAb, and 1.6% HCV Ab prevalence among blood donors, indicating a need for better screening.
Infection with hepatitis B virus (HBV) and hepatitis C virus (HCV) is major global health problem; the transfusion and product of blood are recognized risk factors of acquiring HBV and HCV. Objective: To determine the prevalence of Hepatitis B Surface Antigen, Hepatitis B Core Antibody and Hepatitis C Antibody among blood donors at National Blood Transfusion & Research Center in Sana'a City. Results: from a total of 5000 blood donor participated in the present study tested for HBsAg, HBcAb and HCV only 130 (2.6%), 507 (10.1) and 53(1.6%) was found to be positive for HBsAg, HBcAb and HCV Ab respectively There was a statistically significant difference between HBcAB & HBsAg with p= 0.001 and between age groups and antihepatitice Bc with p=0.04. There was no statistically significant difference between jobs and antihepatitice Bc with p= 0.4, no difference between jobs and hepatitis C with p=0.3, no difference between jobs and hepatitis B sAg with p=0.7, no difference between age groups and Hepatitis BsAg and Hepatitis C Ab with p=0.09 and p=0.7 respectively. Conclusion. Hepatitis B surface antigen and Hepatitis B cor Ab should be tested as A diagnosis test for hepatitis B virus. Health education should concern risk factors and prevention of HBV and HCV infections for public.
No takes yet. Share an insight, caveat, or question.
Safwan Mahmood Qasam (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: